ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,472, issued on Sept. 30, was assigned to The Rockefeller University (New York) and California Institute of Technology (Pasadena, Calif.).

"Human immunodeficiency virus neutralizing antibodies and methods of use thereof" was invented by Johannes Scheid (New York), Michel Nussenzweig (New York), Pamela J. Bjorkman (Altadena, Calif.) and Ron Diskin (Rehovot, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides broadly neutralizing antibodies directed to epitopes of Human Immunodeficiency Virus, or HIV. The invention further provides compositions containing HIV antibodies used for prophylaxis, and methods for diagnosis and treat...